The Association of Multidimensional Sleep Health With HbA1c and Depressive Symptoms in African American Adults With Type 2 Diabetes.

IF 2.9 3区医学 Q2 PSYCHIATRY Psychosomatic Medicine Pub Date : 2024-05-01 DOI:10.1097/PSY.0000000000001298

Jihun Woo, H Matthew Lehrer, Doonya Tabibi, Lauren Cebulske, Hirofumi Tanaka, Mary Steinhardt

{"title":"The Association of Multidimensional Sleep Health With HbA1c and Depressive Symptoms in African American Adults With Type 2 Diabetes.","authors":"Jihun Woo, H Matthew Lehrer, Doonya Tabibi, Lauren Cebulske, Hirofumi Tanaka, Mary Steinhardt","doi":"10.1097/PSY.0000000000001298","DOIUrl":null,"url":null,"abstract":"Objective: Sleep is important for diabetes-related health outcomes. Using a multidimensional sleep health framework, we examined the association of individual sleep health dimensions and a composite sleep health score with hemoglobin A1c (HbA1c) and depressive symptoms among African American adults with type 2 diabetes.Methods: Participants (N = 257; mean age = 62.5 years) were recruited through local churches. Wrist-worn actigraphy and sleep questionnaire data assessed multidimensional sleep health using the RuSATED framework (regularity, satisfaction, alertness, timing, efficiency, duration). Individual sleep dimensions were dichotomized into poor or good sleep health and summed into a composite score. HbA1c was assessed using the DCA Vantage™ Analyzer or A1CNow® Self Check. Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ-9). Regression models examined the association of individual sleep dimensions and composite sleep health with HbA1c and depressive symptoms.Results: Higher composite sleep health scores were associated with a lower likelihood of having greater than minimal depressive symptoms (PHQ-9 ≥ 5) (odds ratio [OR] = 0.578, 95% confidence interval [CI] = 0.461-0.725). Several individual sleep dimensions, including irregularity (OR = 1.013, CI = 1.005-1.021), poor satisfaction (OR = 3.130, CI = 2.095-4.678), and lower alertness (OR = 1.866, CI = 1.230-2.833) were associated with a greater likelihood of having depressive symptoms. Neither composite sleep health scores nor individual sleep dimensions were associated with HbA1c.Conclusions: Better multidimensional sleep health is associated with lower depressive symptoms among African American adults with type 2 diabetes. Longitudinal research is needed to determine the causal association between multidimensional sleep health and depressive symptoms in this population.Trial registry: ClinicalTrials.gov identifier NCT04282395.","PeriodicalId":20918,"journal":{"name":"Psychosomatic Medicine","volume":"86 4","pages":"307-314"},"PeriodicalIF":2.9000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychosomatic Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PSY.0000000000001298","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Sleep is important for diabetes-related health outcomes. Using a multidimensional sleep health framework, we examined the association of individual sleep health dimensions and a composite sleep health score with hemoglobin A1c (HbA1c) and depressive symptoms among African American adults with type 2 diabetes.

Methods: Participants (N = 257; mean age = 62.5 years) were recruited through local churches. Wrist-worn actigraphy and sleep questionnaire data assessed multidimensional sleep health using the RuSATED framework (regularity, satisfaction, alertness, timing, efficiency, duration). Individual sleep dimensions were dichotomized into poor or good sleep health and summed into a composite score. HbA1c was assessed using the DCA Vantage™ Analyzer or A1CNow® Self Check. Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ-9). Regression models examined the association of individual sleep dimensions and composite sleep health with HbA1c and depressive symptoms.

Results: Higher composite sleep health scores were associated with a lower likelihood of having greater than minimal depressive symptoms (PHQ-9 ≥ 5) (odds ratio [OR] = 0.578, 95% confidence interval [CI] = 0.461-0.725). Several individual sleep dimensions, including irregularity (OR = 1.013, CI = 1.005-1.021), poor satisfaction (OR = 3.130, CI = 2.095-4.678), and lower alertness (OR = 1.866, CI = 1.230-2.833) were associated with a greater likelihood of having depressive symptoms. Neither composite sleep health scores nor individual sleep dimensions were associated with HbA1c.

Conclusions: Better multidimensional sleep health is associated with lower depressive symptoms among African American adults with type 2 diabetes. Longitudinal research is needed to determine the causal association between multidimensional sleep health and depressive symptoms in this population.

Trial registry: ClinicalTrials.gov identifier NCT04282395.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

非裔美国 2 型糖尿病成人的多维睡眠健康与 HbA1c 和抑郁症状的关系。

目的睡眠对糖尿病相关的健康结果非常重要。我们采用多维睡眠健康框架，研究了患有 2 型糖尿病的非裔美国成年人中，单个睡眠健康维度和综合睡眠健康评分与血红蛋白 A1c（HbA1c）和抑郁症状之间的关系：通过当地教会招募参与者（N = 257；平均年龄 = 62.5 岁）。腕戴式动作仪和睡眠问卷数据采用 RuSATED 框架（规律性、满意度、警觉性、时间性、效率、持续时间）评估多维睡眠健康状况。单个睡眠维度被二分为睡眠健康状况差或好，并加总为综合得分。使用 DCA Vantage™ Analyzer 或 A1CNow® Self Check 对 HbA1c 进行评估。抑郁症状采用患者健康问卷（PHQ-9）进行评估。回归模型检验了单个睡眠维度和综合睡眠健康状况与 HbA1c 和抑郁症状之间的关联：结果：较高的综合睡眠健康得分与较低的抑郁症状（PHQ-9 ≥ 5）相关（几率比 [OR] = 0.578，95% 置信区间 [CI] = 0.461-0.725）。包括睡眠不规律（OR = 1.013，CI = 1.005-1.021）、满意度差（OR = 3.130，CI = 2.095-4.678）和警觉性较低（OR = 1.866，CI = 1.230-2.833）在内的几个单个睡眠维度与抑郁症状的可能性增加有关。睡眠健康综合评分或单个睡眠维度均与 HbA1c 无关：结论：在患有 2 型糖尿病的非裔美国成年人中，较好的多维睡眠健康与较低的抑郁症状相关。需要进行纵向研究，以确定这一人群中多维睡眠健康与抑郁症状之间的因果关系：试验登记：ClinicalTrials.gov 标识符 NCT04282395。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Psychosomatic Medicine 医学-精神病学

CiteScore

5.10

自引率

0.00%

发文量

258

审稿时长

4-8 weeks

期刊介绍： Psychosomatic Medicine is the official peer-reviewed journal of the American Psychosomatic Society. The journal publishes experimental, clinical, and epidemiological studies on the role of psychological and social factors in the biological and behavioral processes relevant to health and disease. Psychosomatic Medicine is an interdisciplinary peer-reviewed journal devoted to high-quality science on biobehavioral mechanisms, brain-behavior interactions relevant to physical and mental disorders, as well as interventions in clinical and public health settings. Psychosomatic Medicine was founded in 1939 and publishes interdisciplinary research articles relevant to medicine, psychiatry, psychology, and other health-related disciplines. The print journal is published nine times a year; most articles are published online ahead of print. Supplementary issues may contain reports of conferences at which original research was presented in areas relevant to the psychosomatic and behavioral medicine.